• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evidence of prednisolone induced mood change ('steroid euphoria') in patients with chronic obstructive airways disease.慢性阻塞性气道疾病患者中泼尼松龙诱发情绪变化(“类固醇欣快症”)的证据。
Br J Clin Pharmacol. 1988 Dec;26(6):709-13. doi: 10.1111/j.1365-2125.1988.tb05309.x.
2
Assessment of reversibility of airway obstruction in patients with chronic obstructive airways disease.慢性阻塞性气道疾病患者气道阻塞可逆性的评估。
Thorax. 1990 Mar;45(3):190-4. doi: 10.1136/thx.45.3.190.
3
Effects of prednisolone in chronic airflow limitation.泼尼松龙在慢性气流受限中的作用
Lancet. 1984 Jul 28;2(8396):193-6. doi: 10.1016/s0140-6736(84)90481-1.
4
Effects of high dose inhaled beclomethasone dipropionate, 750 micrograms and 1500 micrograms twice daily, and 40 mg per day oral prednisolone on lung function, symptoms, and bronchial hyperresponsiveness in patients with non-asthmatic chronic airflow obstruction.高剂量吸入丙酸倍氯米松(每日两次,剂量分别为750微克和1500微克)及每日40毫克口服泼尼松龙对非哮喘性慢性气流阻塞患者肺功能、症状及支气管高反应性的影响
Thorax. 1993 Apr;48(4):309-16. doi: 10.1136/thx.48.4.309.
5
Psychological changes and improvement in chronic airflow limitation after corticosteroid treatment.皮质类固醇治疗后慢性气流受限患者的心理变化及改善情况
Thorax. 1984 Dec;39(12):924-7. doi: 10.1136/thx.39.12.924.
6
Comparison of oral and depot intra-muscular steroids in assessing steroid-responsiveness in COPD.
COPD. 2004 Apr;1(1):33-40. doi: 10.1081/COPD-120028699.
7
A comparison of the effects of prednisolone and mianserin on ventilatory, exercise and psychometric parameters in patients with chronic obstructive pulmonary disease.
Eur J Clin Pharmacol. 1995;48(1):13-8. doi: 10.1007/BF00202165.
8
Prednisolone in the treatment of airflow obstruction in adults with cystic fibrosis.泼尼松龙治疗成年囊性纤维化患者气流阻塞
Thorax. 1986 Jan;41(1):34-8. doi: 10.1136/thx.41.1.34.
9
Response to corticosteroids in chronic airflow obstruction: relationship to emphysema and airways collapse.慢性气流阻塞对皮质类固醇的反应:与肺气肿和气道塌陷的关系。
Eur Respir J. 1991 Nov;4(10):1185-90.
10
Assessment of steroid responsiveness in patients with chronic airflow obstruction.慢性气流受限患者类固醇反应性的评估。
Lancet. 1982 Aug 14;2(8294):345-8. doi: 10.1016/s0140-6736(82)90545-1.

引用本文的文献

1
Mifepristone decreases nicotine intake in dependent and non-dependent adult rats.米非司酮可减少依赖和非依赖成年大鼠的尼古丁摄入量。
J Psychopharmacol. 2024 Mar;38(3):280-296. doi: 10.1177/02698811241230255. Epub 2024 Feb 8.
2
Pharmacological Management of Steroid-Induced Psychosis: A Review of Patient Cases.类固醇诱导性精神病的药物治疗:患者病例综述
J Pharm Technol. 2021 Apr;37(2):120-126. doi: 10.1177/8755122520978534. Epub 2020 Dec 2.
3
Rate of Corticosteroid-Induced Mood Changes in Patients with Inflammatory Bowel Disease: A Prospective Study.炎症性肠病患者中皮质类固醇诱导的情绪变化发生率:一项前瞻性研究。
J Can Assoc Gastroenterol. 2018 Sep;1(3):99-106. doi: 10.1093/jcag/gwy023. Epub 2018 Jun 4.
4
Oral prednisolone for 4 days does not increase exercise tolerance in men with COPD.口服泼尼松龙 4 天不能提高 COPD 男性的运动耐量。
Chron Respir Dis. 2018 May;15(2):220-222. doi: 10.1177/1479972317721929. Epub 2017 Jul 18.
5
Corticosteroid-related central nervous system side effects.皮质类固醇相关的中枢神经系统副作用。
J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S94-8. doi: 10.4103/0976-500X.120975.
6
Glucocorticoids improve high-intensity exercise performance in humans.糖皮质激素可提高人体高强度运动表现。
Eur J Appl Physiol. 2014 Feb;114(2):419-24. doi: 10.1007/s00421-013-2784-7. Epub 2013 Dec 11.
7
A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy.系统皮质类固醇治疗并发症的监测和管理实用指南。
Allergy Asthma Clin Immunol. 2013 Aug 15;9(1):30. doi: 10.1186/1710-1492-9-30.
8
Short-term glucocorticoid intake improves exercise endurance in healthy recreationally trained women.短期糖皮质激素摄入可提高健康业余训练女性的运动耐力。
Eur J Appl Physiol. 2009 Nov;107(4):437-43. doi: 10.1007/s00421-009-1149-8. Epub 2009 Aug 11.
9
Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management.皮质类固醇引起的不良精神效应:发生率、诊断与管理
Drug Saf. 2000 Feb;22(2):111-22. doi: 10.2165/00002018-200022020-00004.
10
Altered leucocyte trafficking and suppressed tumour necrosis factor alpha release from peripheral blood monocytes after intra-articular glucocorticoid treatment.关节腔内注射糖皮质激素治疗后白细胞转运改变,外周血单核细胞肿瘤坏死因子α释放受抑制。
Ann Rheum Dis. 1998 Dec;57(12):732-7. doi: 10.1136/ard.57.12.732.

本文引用的文献

1
AN ANALYSIS OF MOOD IN NEUROTICS.神经症患者的情绪分析
J Abnorm Psychol. 1964 Dec;69:620-7. doi: 10.1037/h0040902.
2
BRONCHODILATORS AND CORTICOSTEROIDS IN CHRONIC BRONCHITIS AND EMPHYSEMA.慢性支气管炎和肺气肿中的支气管扩张剂与皮质类固醇
Br Med J. 1963 Dec 14;2(5371):1509-12. doi: 10.1136/bmj.2.5371.1509.
3
The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population.在职人群中呼吸道症状的意义及慢性支气管炎的诊断
Br Med J. 1959 Aug 29;2(5147):257-66. doi: 10.1136/bmj.2.5147.257.
4
An inventory for measuring depression.一份用于测量抑郁的量表。
Arch Gen Psychiatry. 1961 Jun;4:561-71. doi: 10.1001/archpsyc.1961.01710120031004.
5
Prevalence by Self-report questionnaire and recognition by nonpsychiatric physicians.通过自我报告问卷得出的患病率以及非精神科医生的识别情况。
Arch Gen Psychiatry. 1980 Sep;37(9):999-1004. doi: 10.1001/archpsyc.1980.01780220037003.
6
Side effects of corticosteroid therapy. Psychiatric aspects.皮质类固醇疗法的副作用。精神方面。
Arch Gen Psychiatry. 1981 Apr;38(4):471-7. doi: 10.1001/archpsyc.1981.01780290105011.
7
Use of multivariate measures of disability in health surveys.健康调查中残疾的多变量测量方法的应用。
J Epidemiol Community Health. 1983 Dec;37(4):296-304. doi: 10.1136/jech.37.4.296.
8
Some norms and reliability data for the State--Trait Anxiety Inventory and the Zung Self-Rating Depression scale.
Br J Clin Psychol. 1983 Nov;22 (Pt 4):245-9. doi: 10.1111/j.2044-8260.1983.tb00610.x.
9
Psychological changes and improvement in chronic airflow limitation after corticosteroid treatment.皮质类固醇治疗后慢性气流受限患者的心理变化及改善情况
Thorax. 1984 Dec;39(12):924-7. doi: 10.1136/thx.39.12.924.
10
Clinical improvement after treatment with prednisolone in chronic airways obstruction in absence of change in lung function tests.
Lancet. 1986 Feb 1;1(8475):276. doi: 10.1016/s0140-6736(86)90814-7.

慢性阻塞性气道疾病患者中泼尼松龙诱发情绪变化(“类固醇欣快症”)的证据。

Evidence of prednisolone induced mood change ('steroid euphoria') in patients with chronic obstructive airways disease.

作者信息

Swinburn C R, Wakefield J M, Newman S P, Jones P W

机构信息

Department of Medicine, Middlesex Hospital, London.

出版信息

Br J Clin Pharmacol. 1988 Dec;26(6):709-13. doi: 10.1111/j.1365-2125.1988.tb05309.x.

DOI:10.1111/j.1365-2125.1988.tb05309.x
PMID:3242575
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1386585/
Abstract
  1. It is a clinical impression that some patients given oral corticosteroids develop a sense of wellbeing that is 'inappropriate' to improvements in physical health. This has been termed steroid 'euphoria', but unlike steroid-induced psychosis it has not been documented. 2. To test for the size and frequency of this phenomenon, 20 patients with severe chronic obstructive airways disease (mean FEV1 0.86 l) were given 30 mg of prednisolone for 14 days, after a period of placebo administration in a single-blind study. 3. Lung spirometry and arterial saturation during exercise were measured serially, together with established measures of mood state. 4. No changes in spirometry or arterial saturation during exercise were detected until 7 days of active therapy. 5. Mood state did not change during the placebo period, but small significant reductions in anxiety and depression were measured after 3 days of prednisolone and before any measurable improvement in lung function. Mood state did not then further improve, despite measurable improvements in lung spirometry. 6. This is evidence that prednisolone may produce a mild 'inappropriate' sense of wellbeing within a population receiving the drug, rather than as an occasional idiosyncratic response.
摘要
  1. 临床上观察到,一些接受口服皮质类固醇治疗的患者会产生一种与身体健康改善情况“不相称”的幸福感。这被称为类固醇“欣快感”,但与类固醇诱发的精神病不同,尚未有文献记载。2. 为了测试这种现象的规模和发生频率,在一项单盲研究中,20名重度慢性阻塞性气道疾病患者(平均第一秒用力呼气容积为0.86升)在接受了一段时间的安慰剂治疗后,服用30毫克泼尼松龙,持续14天。3. 连续测量运动期间的肺功能和动脉血氧饱和度,以及既定的情绪状态指标。4. 在积极治疗7天之前,未检测到运动期间肺功能或动脉血氧饱和度的变化。5. 情绪状态在安慰剂期间没有变化,但在服用泼尼松龙3天后,在肺功能有任何可测量的改善之前,焦虑和抑郁有小幅显著降低。尽管肺功能有可测量的改善,但情绪状态随后并未进一步改善。6. 这证明泼尼松龙可能会在接受该药物治疗的人群中产生一种轻微的“不相称”幸福感,而不是偶尔的特异反应。